Horizon Discovery Ltd.

We are a fully integrated life science company that provides enabling products, services and research programs to clients engaged at every stage of the healthcare continuum from sequence to treatment. Horizon was founded by Dr Chris Torrance and Professor Alberto Bardelli in 2007 when they came across an impressive gene editing platform, rAAV, which enabled the ability to tailor-make cell lines with virtually any genomic modification. Since teaming up in September 2007 with current CEO Dr Darrin M Disley, the company has grown rapidly, with offices in the UK, Europe and the U.S., and now supplies advanced research tools and expert services to over 1,600 organizations engaged in genomics research and the development of personalized medicines around the world, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers.